Market Outlook

By 2035, the U.S. Patient Monitoring Devices Market is expected to reach approximately USD 32.14 billion, expanding at 10.50% CAGR during 2026–2035. The market was valued at approximately USD 11.84 billion in 2025, following an estimated expansion from USD 7.90 billion in 2021, USD 8.70 billion in 2022, USD 9.65 billion in 2023, and USD 10.72 billion in 2024. Historical analysis covers 2021–2024, 2025 is the base year, and all market values in this report are expressed in USD billions.

The U.S. patient monitoring devices industry is moving from a predominantly hospital-centered equipment category into a connected clinical surveillance ecosystem spanning intensive care, emergency departments, operating rooms, general wards, ambulatory clinics, physician practices, long-term care facilities, and patients’ homes. The economic value of monitoring is increasingly determined not by the monitor alone, but by how effectively the technology captures physiological deterioration, reduces manual observations, supports clinical prioritization, enables earlier intervention, and extends surveillance beyond the hospital.

The scale of the U.S. healthcare delivery system creates a large installed base for monitoring technology. The country has approximately 6,100 hospitals, more than 907,000 staffed hospital beds, and approximately 35.7 million hospital admissions annually. More than 3,500 community hospitals operate as part of health systems, making enterprise standardization, interoperability, centralized monitoring, and multiyear procurement contracts increasingly important competitive factors.

Demand is reinforced by the chronic disease profile of the United States. Nearly half of U.S. adults have hypertension, more than 38 million Americans have diabetes, respiratory diseases require continuous oxygenation and ventilation surveillance, and cardiovascular disease remains a major cause of hospitalization and mortality. At the same time, the U.S. population age 65 and older reached approximately 61.2 million in 2024, representing about 18% of the national population. Older patients are more likely to require hospitalization, multimorbidity management, post-acute follow-up, glucose surveillance, cardiac rhythm monitoring, respiratory monitoring, fall-risk assessment, and remote physiological monitoring.

The market is therefore shifting toward continuous and predictive surveillance. Conventional bedside monitors will remain essential, but incremental value creation through 2035 will increasingly come from wearable sensors, wireless telemetry, continuous glucose monitoring, ambulatory cardiac monitoring, capnography, pulse oximetry, non-invasive hemodynamic monitoring, AI-assisted alarm management, remote patient monitoring, central surveillance platforms, and software capable of converting multiple physiological signals into clinically actionable information.

Hospital procurement is also changing. Health systems are increasingly evaluating monitoring platforms according to total workflow economics rather than acquisition price. Procurement committees are focusing on nursing workload, alarm burden, device utilization, interoperability with electronic health records, cybersecurity, monitoring continuity during patient transport, disposable sensor economics, service contracts, central-station scalability, and the ability to support hospital-at-home or remote monitoring programs.

The long-term commercial opportunity is consequently larger than conventional monitor replacement. Manufacturers capable of connecting acute-care monitoring, ambulatory surveillance, home monitoring, analytics, consumables, and clinical workflow software into one architecture will be positioned to capture a disproportionate share of U.S. market growth.

 

Introduction

According to the U.S. Patient Monitoring Devices Market Report, patient monitoring has become one of the foundational technology layers of modern U.S. healthcare delivery. Monitoring devices continuously or intermittently measure physiological variables such as heart rate, electrocardiographic activity, blood pressure, blood oxygen saturation, respiratory rate, carbon dioxide levels, temperature, glucose, cerebral activity, cardiac output, fetal heart rate, and other indicators used to assess patient stability and detect deterioration.

The market includes multiparameter bedside monitors, cardiac monitoring and telemetry systems, ambulatory ECG devices, blood glucose monitoring systems, respiratory and oxygenation monitors, capnography systems, hemodynamic monitoring products, neurological monitoring systems, fetal and neonatal monitors, temperature monitoring technologies, wearable medical sensors, and connected remote-monitoring equipment. The report focuses on medical-grade patient monitoring devices and associated clinically integrated monitoring platforms rather than consumer-only fitness products or general telehealth services without a medical monitoring component.

The U.S. is particularly attractive for patient monitoring manufacturers because it combines high healthcare expenditure, sophisticated hospital infrastructure, advanced intensive-care capacity, strong physician adoption of digital technologies, growing reimbursement support for remote monitoring, large chronic-disease populations, and an established regulatory pathway for connected medical devices.

National healthcare expenditure reached approximately USD 5.3 trillion in 2024, while hospital expenditures alone exceeded USD 1.63 trillion. This creates a substantial addressable infrastructure budget, although hospitals are simultaneously under pressure to control labor costs and improve operating efficiency. Patient monitoring technologies that automate measurement, enable centralized surveillance, reduce repetitive nursing tasks, and identify deterioration before an expensive escalation of care can therefore achieve both clinical and economic relevance.

Monitoring is also moving outside traditional high-acuity areas. Historically, continuous multiparameter surveillance was concentrated in intensive care units, operating rooms, emergency departments, neonatal intensive care units, and cardiac units. Wireless and wearable monitoring now allows health systems to expand surveillance into medical-surgical floors, step-down units, ambulatory settings, recovery areas, and patients’ homes.

This expansion is significant because U.S. hospitals face persistent clinical workforce constraints. Rather than simply adding staff for every additional monitored patient, health systems are exploring centralized monitoring centers, virtual nursing, remote observation, automated early-warning scores, and exception-based alarm management. The monitor therefore increasingly functions as part of a hospital-wide information architecture rather than as an isolated bedside asset.

Remote monitoring introduces another growth layer. Medicare has covered remote physiological monitoring since 2018, and use has increased substantially. Medicare payments for remote patient monitoring exceeded USD 500 million in 2024. Blood pressure cuffs, weight scales, pulse oximeters, glucose monitors, and other connected devices can transmit measurements directly to clinical teams, supporting chronic disease management and post-discharge care.

From 2026 to 2035, competitive advantage will increasingly depend on manufacturers’ ability to deliver reliable physiological measurement while solving data overload. Generating more measurements is no longer sufficient. U.S. providers need systems that distinguish meaningful deterioration from noise, prioritize patients, reduce false alarms, integrate data across care settings, and create usable information for nurses and physicians.

 

Key Market Drivers: What’s Fueling the U.S. Patient Monitoring Devices Market Boom?

The strongest structural driver is the increasing clinical burden of chronic disease. Nearly half of U.S. adults have hypertension, representing approximately 120 million people. Hypertension is particularly relevant to patient monitoring because blood pressure measurement crosses almost every care setting, from primary care and home monitoring to intensive care and perioperative medicine. Connected blood pressure devices are also among the simplest entry points for remote physiological monitoring programs.

Diabetes creates another large recurring monitoring population. Approximately 38.4 million Americans have diabetes, equivalent to more than one in ten people, while nearly 98 million U.S. adults have prediabetes. Continuous glucose monitoring has fundamentally altered diabetes surveillance by shifting patients from episodic finger-stick measurements toward continuous trend information, predictive alerts, mobile connectivity, and data sharing with caregivers and healthcare professionals. Expanded access to CGM creates one of the most attractive recurring sensor opportunities within the broader patient monitoring devices market.

Respiratory disease also supports demand. Diagnosed chronic obstructive pulmonary disease affects millions of adults, with prevalence rising sharply among older age groups. Oxygen saturation, respiratory rate, carbon dioxide monitoring, sleep monitoring, and ventilation surveillance are important across emergency care, inpatient medicine, postoperative recovery, home respiratory care, and sleep medicine. As hospitals attempt to identify respiratory deterioration earlier, continuous pulse oximetry and capnography are moving beyond intensive care and operating rooms into broader ward-based applications.

The aging U.S. population compounds these disease trends. The number of Americans age 65 and older reached approximately 61.2 million in 2024 and grew substantially faster than the working-age population during the first half of the decade. Older patients frequently have multiple chronic conditions and are more vulnerable to arrhythmia, heart failure, respiratory deterioration, diabetes complications, postoperative events, falls, and medication-related instability. These characteristics increase monitoring intensity both inside hospitals and after discharge.

A second major market driver is the expansion of monitoring beyond the ICU. U.S. hospitals are increasingly interested in continuous surveillance of patients on general medical-surgical floors because deterioration can occur between scheduled manual vital-sign observations. Wearable multiparameter sensors, wireless pulse oximetry, continuous respiratory monitoring, and central surveillance can potentially identify abnormal patterns earlier while allowing patients greater mobility than conventional wired monitoring.

This transition changes the market’s addressable bed base. Continuous monitoring historically targeted a relatively limited portion of hospital beds. Wireless devices make it technically possible to monitor a much larger proportion of the more than 907,000 staffed U.S. hospital beds when clinically justified. Even selective deployment across postoperative, respiratory, cardiac, and high-risk medical-surgical populations creates a substantial incremental device opportunity.

A third driver is hospital labor economics. Nurses remain responsible for repeated vital-sign measurement, patient reassessment, alarm response, documentation, and escalation. Connected monitors capable of automatically transferring validated observations into electronic records can reduce duplicate documentation and improve data availability. The purchasing argument therefore extends beyond device performance to minutes of staff time saved per patient, reduced manual transcription, improved surveillance coverage, and potentially earlier clinical response.

A fourth driver is the growth of remote physiological monitoring. Connected scales, blood pressure monitors, pulse oximeters, ECG devices, and glucose technologies enable clinicians to follow chronic conditions without requiring every measurement to occur during an office visit. This is particularly relevant for hypertension, heart failure, diabetes, cardiac rhythm disorders, pulmonary disease, and post-discharge recovery.

Remote monitoring also has strategic importance in rural healthcare. Approximately 1,800 U.S. community hospitals are classified as rural, while more than 150 rural hospitals closed between 2010 and 2025. Where physical access to specialty care is constrained, connected monitoring can support centralized clinical oversight, although broadband availability, patient digital literacy, device logistics, and reimbursement execution remain barriers.

A fifth driver is the transition toward continuous cardiac monitoring. Cardiac monitoring is one of the largest product categories in the U.S. market. Traditional ECG and Holter monitoring increasingly coexist with mobile cardiac telemetry, patch-based monitors, implantable loop recorders, wearable ECG technologies, and cloud-based arrhythmia analytics. These technologies increase the duration of observable patient data and improve the probability of capturing intermittent arrhythmias that could be missed during short diagnostic windows.

A sixth driver is the expansion of maternal and neonatal monitoring. The United States recorded more than 3.6 million births in 2024, while approximately 10.4% of births were preterm. Fetal heart monitoring, maternal vital-sign surveillance, neonatal cardiorespiratory monitoring, pulse oximetry, incubator-linked monitoring, and NICU surveillance therefore remain clinically necessary device categories. Higher-risk pregnancies, maternal comorbidities, and persistent preterm-birth burden support investment in more connected maternal and neonatal monitoring architectures.

A seventh driver is reimbursement and the increasing institutionalization of connected care. Medicare reimbursement has helped transform remote patient monitoring from a technology experiment into a reimbursable clinical workflow. Although billing rules and program oversight continue evolving, the existence of dedicated reimbursement pathways makes it easier for providers to justify device deployment when monitoring is integrated into a legitimate care-management model.

An eighth driver is hospital system consolidation. More than 3,500 U.S. community hospitals are part of health systems. Large integrated delivery networks can standardize monitoring platforms across dozens or even hundreds of sites, creating high-value enterprise contracts. Vendor decisions therefore increasingly involve central stations, data integration, device fleets, cybersecurity, service coverage, disposable sensors, network architecture, and lifecycle management rather than individual bedside monitors.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. patient monitoring devices market is increasingly centered on continuous measurement, wireless connectivity, sensor miniaturization, predictive analytics, workflow integration, and movement between care environments.

Wearable multiparameter monitoring is one of the most consequential developments. Traditional monitors physically tether patients through multiple cables. New wearable architectures can continuously collect selected combinations of oxygen saturation, respiratory rate, pulse rate, blood pressure, temperature, ECG, and movement data while allowing patients to ambulate. This supports enhanced recovery, earlier mobilization, continuous ward surveillance, and monitoring during transport.

The strategic opportunity is not simply replacing a bedside monitor with a wearable device. The larger opportunity is expanding monitoring into patients who previously received intermittent observations. If wireless monitoring allows a hospital to safely extend surveillance from critical care into selected general-ward populations, manufacturers can expand the number of continuously monitored patients without requiring ICU-style infrastructure at every bed.

AI-assisted surveillance is another major innovation direction. Modern hospitals generate enormous quantities of physiological data, but clinicians cannot manually interpret every waveform and trend simultaneously. Algorithms are increasingly being developed to identify arrhythmias, respiratory deterioration, hemodynamic instability, abnormal glucose patterns, seizure activity, and combinations of vital-sign changes that may signal worsening clinical condition.

The commercial value of AI will depend on specificity rather than alert volume. Alarm fatigue remains an important workflow problem. Systems that create additional non-actionable alerts can increase clinical burden instead of reducing it. Manufacturers that demonstrate clinically useful sensitivity while minimizing false alarms and presenting clear escalation priorities will have stronger procurement arguments.

Interoperability is becoming equally important. Hospitals expect patient-monitoring data to flow into electronic medical records, central stations, mobile clinical applications, alarm-management systems, and analytics platforms. Proprietary closed architectures are becoming less attractive to large integrated delivery networks that need to standardize technology across heterogeneous facilities.

Continuous glucose monitoring illustrates how monitoring can shift from an episodic measurement product to a recurring digital ecosystem. Modern CGM products combine disposable sensors, smartphone applications, cloud connectivity, alerts, trend analytics, and integration with diabetes-management systems. Longer sensor wear and wider eligibility can reduce friction and increase the number of monitored patient-days.

Hemodynamic monitoring is also moving toward less invasive configurations. Advanced systems increasingly aim to provide clinically useful cardiovascular information with fewer invasive lines while combining pressure, flow, oxygenation, and predictive variables. This matters in operating rooms, intensive care units, procedural environments, and higher-acuity medical settings where clinicians must balance information depth against procedural risk and complexity.

Centralized surveillance represents another innovation layer. Instead of requiring every alarm to be interpreted exclusively at the bedside, health systems can establish monitoring hubs where trained staff oversee multiple patients across hospital units or facilities. Such models can support telemetry, oxygen saturation, respiratory monitoring, virtual observation, and deterioration detection. The economic rationale becomes stronger as health systems consolidate and attempt to manage staffing more flexibly.

Cybersecurity and data integrity are emerging as product-development requirements rather than secondary IT considerations. Connected monitors communicate across hospital networks and, increasingly, cloud environments. Health systems therefore evaluate authentication, software updates, network segmentation, encryption, downtime procedures, and vendor support as part of clinical device procurement.

Regulatory scrutiny is also shaping innovation. U.S. regulators continue to authorize sensor-based digital health technologies while emphasizing accurate physiological measurement. Blood pressure illustrates the issue particularly well: consumer demand for cuffless or wearable measurement is rising, but inaccurate measurements can lead directly to clinical errors. Companies able to establish regulatory authorization and credible validation will have a significant trust advantage over consumer-oriented products making unsupported medical claims.

 

Segmentation Insights

The U.S. Patient Monitoring Devices Market is segmented on the basis of product category, application, end user, technology type, and region.

 

By Product Category

Cardiac Monitoring Devices

Cardiac monitoring devices represent the largest individual product value pool in the U.S. market. The category includes ECG machines, Holter monitors, event monitors, mobile cardiac telemetry, wearable ECG patches, bedside cardiac monitors, implantable loop recorders, and associated rhythm-analysis systems.

Demand is supported by arrhythmia prevalence, cardiovascular hospitalization, stroke-risk assessment, post-procedure monitoring, and increasing diagnostic use of extended ambulatory ECG. Patch-based monitoring has reduced the practical burden associated with conventional multi-lead ambulatory systems and enables longer observation periods. Through 2035, growth will increasingly come from long-duration monitoring, cloud-based interpretation, AI-assisted rhythm analysis, and integration between hospital and ambulatory cardiac data.

Multi-Parameter Patient Monitoring Devices

Multiparameter monitors remain the core infrastructure product within acute-care monitoring. These systems can combine ECG, blood pressure, SpO2, respiratory rate, temperature, capnography, and other measurements on a common bedside or transport platform.

The U.S. installed base is substantial because these monitors are required across ICUs, operating rooms, emergency departments, step-down units, neonatal units, recovery rooms, and other high-acuity settings. Replacement cycles remain important, but hospitals increasingly purchase monitoring as an ecosystem involving bedside displays, transport monitors, central stations, software, device connectivity, sensors, and service.

Growth will be strongest for modular, scalable platforms that can follow patients between acuity levels and reduce the need to disconnect and reconnect monitoring during transport.

Blood Glucose Monitoring Systems

Blood glucose monitoring is among the fastest-growing patient monitoring categories because of the large U.S. diabetes population and continued migration toward continuous glucose monitoring. Approximately 38.4 million Americans have diabetes, providing a large recurring user base, while prediabetes affects an even larger population.

The segment includes self-monitoring blood glucose meters, test strips, lancets, continuous glucose monitoring systems, sensors, transmitters, readers, and connected applications. CGM is increasingly becoming the primary innovation and value-growth engine because sensors generate recurring revenue and provide substantially richer data than intermittent finger-stick testing.

Expansion beyond intensive insulin therapy and continued improvement in sensor wear duration can meaningfully enlarge the addressable U.S. user population through 2035.

Respiratory Monitoring Devices

Respiratory monitoring includes pulse oximeters, capnography systems, respiratory-rate monitors, spirometry-linked monitoring, sleep-monitoring technologies, and other systems designed to assess ventilation and oxygenation.

Clinical demand extends across respiratory disease, anesthesia, postoperative recovery, emergency care, critical care, sleep medicine, and home healthcare. Continuous respiratory surveillance is becoming particularly important for patients receiving opioids or sedation and for high-risk postoperative populations.

The product category will benefit from smaller sensors, wireless connectivity, better motion tolerance, improved signal processing, and greater adoption outside the ICU.

Hemodynamic and Blood Pressure Monitoring Devices

This category includes non-invasive blood pressure monitors, invasive pressure monitoring, cardiac output monitoring, arterial pressure systems, advanced hemodynamic platforms, and connected home blood pressure devices.

The enormous hypertension population creates a large low-acuity monitoring base, while advanced hemodynamic monitoring remains a premium hospital market. Hospitals increasingly seek platforms that provide actionable information with fewer invasive procedures and that support goal-directed fluid or cardiovascular management.

Home blood pressure monitoring is expected to become more connected, but regulatory credibility will be critical as wearable and cuffless technologies enter the market.

Neuromonitoring Devices

Neuromonitoring comprises EEG systems, cerebral function monitors, intracranial pressure monitoring, cerebral oximetry, sleep-related neurological monitoring, and other technologies used to measure neurological activity or cerebral status.

The segment has attractive growth potential because neurological monitoring is moving toward more portable configurations and broader applications in emergency, intensive-care, surgical, and outpatient settings. Simplified electrode placement, wireless sensors, automated seizure detection, AI-assisted EEG interpretation, and wearable neurological diagnostics can reduce reliance on specialized laboratory infrastructure.

Fetal and Neonatal Monitoring Devices

Fetal and neonatal monitoring remains a clinically essential market because more than 3.6 million births occur annually in the United States and approximately one in ten births is preterm.

The segment includes fetal heart-rate monitors, maternal monitoring systems, contraction monitors, neonatal cardiorespiratory monitors, neonatal pulse oximetry, cerebral monitoring, temperature systems, and NICU surveillance technology. Hospitals increasingly seek integrated maternal-fetal monitoring platforms capable of linking labor-and-delivery data with enterprise patient records and centralized surveillance.

Temperature, Weight and Other Physiological Monitoring Devices

Temperature monitoring, connected weight measurement, and other specialized physiological devices represent smaller individual categories but are widely used across hospitals, clinics, chronic disease programs, and home settings.

Connected scales are especially important in heart failure monitoring, where rapid weight changes can indicate fluid accumulation. Temperature sensors remain important in infection surveillance, perioperative medicine, neonatal care, and continuous wearable monitoring. These smaller device categories become strategically more important when incorporated into multiparameter or remote-monitoring platforms.

 

By Application

Critical Care and Acute Patient Surveillance

Critical care represents the highest-acuity monitoring application. ICU patients may require continuous ECG, invasive and non-invasive pressure monitoring, oxygen saturation, capnography, temperature, cardiac output, neurological assessment, and other measurements.

Hospitals prioritize accuracy, redundancy, alarm reliability, interoperability, and rapid clinical visualization in this environment. Critical-care monitoring is mature, but replacement demand remains durable because technological obsolescence, software support, cybersecurity, network integration, and broader enterprise standardization encourage periodic capital upgrades.

Cardiovascular and Hypertension Management

Cardiovascular monitoring spans inpatient telemetry, diagnostic ECG, ambulatory rhythm monitoring, blood pressure measurement, heart failure monitoring, and post-procedure surveillance.

Nearly 120 million U.S. adults have hypertension, making cardiovascular monitoring one of the broadest applications in healthcare. Growth will be particularly strong where hospital monitoring, ambulatory rhythm analysis, and home blood pressure monitoring converge into longitudinal cardiovascular-management models.

Diabetes Management

Diabetes monitoring represents one of the most consumer-facing but clinically integrated applications within the market. Continuous glucose information allows patients and clinicians to understand time-in-range, nocturnal patterns, post-meal excursions, and trends that cannot be captured through isolated glucose measurements.

As CGM eligibility expands and sensor duration improves, the market will increasingly resemble a recurring connected-device subscription model rather than a conventional durable-device purchase.

Respiratory and Sleep Monitoring

Respiratory monitoring covers acute pulmonary disease, postoperative respiratory surveillance, anesthesia, home oxygen management, COPD, sleep-disordered breathing, and other conditions affecting ventilation or oxygenation.

Approximately 30% of U.S. adults report sleeping less than seven hours per day, highlighting the scale of sleep-related health concerns, although not all represent clinical sleep disorders. Diagnostic and therapeutic sleep ecosystems increasingly incorporate wearable sensors, oxygen saturation, airflow, respiratory effort, and connected home testing.

Neurological Monitoring

Neurological monitoring applications include seizure detection, epilepsy management, neurocritical care, brain injury, anesthesia-related cerebral surveillance, intraoperative monitoring, and sleep diagnostics.

The strategic opportunity lies in reducing the physical and specialist burden associated with traditional neuromonitoring. Portable or wearable systems that allow faster setup in emergency departments, hospital wards, and home environments may expand the number of patients evaluated.

Maternal, Fetal and Neonatal Monitoring

Maternal and neonatal monitoring is driven by pregnancy volume, high-risk pregnancies, preterm births, cesarean deliveries, and the need for continuous surveillance during labor and neonatal intensive care.

The U.S. recorded approximately 3.63 million births in 2024, while the preterm birth rate remained approximately 10.4%. These volumes sustain recurring demand for fetal monitoring transducers, maternal monitoring, neonatal sensors, pulse oximetry, temperature monitoring, and central surveillance software.

 

By End User

Hospitals and Integrated Health Systems

Hospitals represent the dominant end-user segment because most high-acuity continuous monitoring occurs within inpatient facilities. The U.S. has more than 907,000 staffed hospital beds and approximately 35.7 million admissions annually, creating a substantial installed base.

The purchasing environment is increasingly system-level. Large health systems prefer standardized architectures that reduce training requirements, support centralized maintenance, simplify sensor inventory, connect with common electronic records, and permit enterprise monitoring.

Hospital purchasing decisions are consequently becoming less transactional. Vendors are evaluated on hardware reliability, software, service coverage, network architecture, alarm management, implementation capacity, cybersecurity, consumable economics, and lifecycle cost.

Ambulatory Clinics and Physician Practices

Cardiology, endocrinology, pulmonology, sleep medicine, neurology, obstetrics, and primary-care practices use patient monitoring technologies for both diagnosis and chronic disease management.

These customers typically prioritize smaller footprints, ease of deployment, low administrative burden, reimbursement support, cloud connectivity, and rapid data interpretation. Ambulatory ECG, CGM, blood pressure monitoring, sleep diagnostics, and remote-monitoring kits are particularly relevant.

Ambulatory Surgery Centers and Procedural Facilities

ASCs require reliable perioperative monitoring but operate under different economics from large hospitals. Equipment must be compact, durable, easy to maintain, and appropriate for high-throughput procedural workflows.

As more procedures shift into outpatient settings, demand for multiparameter monitors, pulse oximetry, capnography, ECG, temperature monitoring, and recovery-room surveillance will increase.

Home Healthcare and Remote Monitoring Providers

Home monitoring is expected to be one of the fastest-growing end-user categories through 2035. Connected blood pressure cuffs, scales, pulse oximeters, ECG devices, glucose sensors, and other technologies can support chronic disease management without requiring physical visits for every measurement.

Medicare RPM payments exceeding USD 500 million in 2024 demonstrate that remote monitoring has moved beyond pilot-stage utilization. Providers, however, will increasingly be judged on whether programs produce clinically useful engagement rather than merely generating device transmissions.

Long-Term Care, Rehabilitation and Post-Acute Facilities

Long-term care and rehabilitation facilities manage large populations of older and medically complex patients. Monitoring requirements include blood pressure, oxygen saturation, glucose, temperature, cardiac rhythm, respiratory status, and fall-related surveillance.

Wireless and centralized monitoring are particularly attractive because these settings face staffing constraints while managing populations at elevated risk for deterioration and hospital transfer.

 

By Technology Type

Conventional Bedside and Fixed Monitoring

Fixed bedside monitors will remain a foundational technology throughout the forecast period. High-acuity environments require large displays, multiple simultaneous parameters, robust alarm capability, integration with invasive sensors, and continuous power and network connectivity.

Growth will be slower than in wearables, but replacement cycles and hospital expansion will preserve a large recurring market.

Portable and Transport Monitoring

Portable monitoring enables continuity when patients move between emergency departments, imaging, operating rooms, ICUs, recovery areas, and general wards. Hospitals increasingly prefer monitoring modules that can remain connected to the same patient during transport and automatically reconnect to central infrastructure.

This reduces data gaps and repeated sensor setup while improving workflow.

Wireless and Wearable Monitoring

Wireless monitoring is expected to represent one of the fastest-growing technology segments. Patches, wearable pulse oximeters, ambulatory ECG systems, wireless temperature sensors, wearable neurological technologies, and other form factors can expand continuous surveillance without restricting patient movement.

The strongest hospital use case is likely to be continuous surveillance of selected general-ward patients rather than replacement of full ICU monitoring.

Remote and Cloud-Connected Monitoring

Cloud-connected monitoring enables data generated at home or across distributed facilities to be reviewed by centralized clinical teams. This model is particularly relevant for hypertension, diabetes, heart failure, cardiac rhythm disorders, respiratory disease, and post-discharge care.

The segment combines devices with connectivity, dashboards, alert management, workflow integration, and clinical services. Manufacturers that can simplify deployment while maintaining medical-device reliability will be well positioned.

AI-Enabled and Predictive Monitoring

AI-enabled monitoring represents a strategic software layer across all product categories. Algorithms can help detect arrhythmias, prioritize EEG abnormalities, identify deterioration patterns, reduce alarm burden, and convert multivariable physiological data into early-warning information.

Commercial success will depend on prospective evidence, workflow integration, regulatory positioning, explainability, and the ability to show that algorithms improve clinical efficiency rather than merely generate additional alerts.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Patient Monitoring Devices Market is geographically segmented into the South, West, Northeast, and Midwest. Regional demand differs according to population, age structure, chronic disease prevalence, hospital density, large health-system presence, academic medical center concentration, outpatient migration, rural access challenges, technology adoption, and payer economics.

The South is estimated to represent the largest regional market at approximately USD 4.64 billion in 2025, while the West is expected to record the fastest growth through 2035. The Northeast remains an important premium-technology and academic-adoption market, while the Midwest provides a large and stable hospital, chronic-disease, and integrated-delivery-system opportunity.

South

The South represents approximately USD 4.64 billion in 2025 and is projected to approach USD 12.69 billion by 2035, supported by an estimated regional CAGR of approximately 10.6%.

For this report, the South includes Delaware, District of Columbia, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas.

Texas is one of the most important individual patient monitoring markets in the United States. Its population exceeded 31 million in 2024 and has continued growing rapidly. Houston, Dallas-Fort Worth, Austin, and San Antonio contain major tertiary hospitals, academic medical centers, cardiovascular programs, cancer facilities, pediatric hospitals, and large integrated health systems. The state provides significant demand for multiparameter monitoring, cardiac telemetry, glucose monitoring, fetal monitoring, remote chronic-disease management, and emergency-care technologies.

Florida is similarly important but has a different demographic demand profile. More than one-fifth of Florida residents are age 65 or older, making the state particularly attractive for cardiac monitoring, blood pressure monitoring, glucose management, respiratory surveillance, post-acute monitoring, and home-based patient monitoring. Large retirement populations also support outpatient cardiology and chronic disease management.

Georgia and North Carolina are important growth states because of expanding populations and substantial health-system investment. North Carolina combines large provider systems with a significant medical technology and research environment. Georgia’s Atlanta-centered hospital market creates concentrated demand for enterprise patient monitoring, specialty pediatric monitoring, cardiovascular diagnostics, and hospital-based surveillance.

Virginia and Maryland provide sophisticated hospital and academic markets associated with major metropolitan areas and federal healthcare activity. These states show strong potential for advanced monitoring, data integration, neurological surveillance, and centralized monitoring platforms.

Tennessee contains major healthcare corporate activity and important regional medical centers. Nashville in particular is influential in U.S. hospital operations and healthcare services, making Tennessee strategically relevant for vendors attempting to develop health-system partnerships.

Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia have elevated burdens of cardiovascular, metabolic, and respiratory disease in many communities. These states provide significant need for blood pressure, diabetes, cardiac, respiratory, and remote monitoring. Rural access limitations strengthen the potential clinical value of connected home monitoring, although provider finances and broadband availability can affect adoption.

The South is expected to retain the largest regional share through 2035 because it combines population growth, older adult migration, large chronic-disease populations, expanding hospital networks, and significant rural-care needs.

West

The West represented an estimated USD 2.72 billion in 2025 and is projected to reach approximately USD 8.14 billion by 2035, making it the fastest-growing U.S. region at an estimated CAGR of approximately 11.6%.

The region includes Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Utah, Wyoming, Alaska, California, Hawaii, Oregon, and Washington.

California is the largest patient monitoring market in the West. With a population exceeding 39 million, California offers scale across academic hospitals, integrated delivery networks, specialty centers, outpatient practices, technology companies, medtech manufacturers, and digital-health developers.

The state is particularly important for continuous glucose monitoring, ambulatory cardiac technologies, AI-enabled monitoring, wearable medical sensors, remote monitoring, neonatal technology, and connected hospital infrastructure. California’s combination of large provider systems and technology development makes it an influential early-adoption market.

Arizona and Nevada are notable growth markets because of rapid population expansion and significant older adult communities. This supports increased utilization of cardiovascular monitoring, diabetes technology, respiratory monitoring, hospital surveillance, and home monitoring.

Washington and Oregon have sophisticated integrated health systems and strong adoption of digital healthcare infrastructure. Their provider markets are well suited to connected patient monitoring, remote chronic disease management, and enterprise-level surveillance.

Colorado and Utah combine population growth, large regional health systems, academic care, and technology-oriented healthcare markets. These states are attractive for wireless monitoring, central surveillance, connected ambulatory devices, and health-system standardization.

Idaho, Montana, Wyoming, New Mexico, and Alaska have smaller absolute populations but important rural and geographic access challenges. Remote physiological monitoring can be strategically valuable where patients must travel long distances for specialty care.

Hawaii presents a distinctive island geography in which connected monitoring can reduce unnecessary travel and improve continuity between tertiary centers and patients living outside major population hubs.

The West should gain market share through 2035 because of faster adoption of digital monitoring, wearable sensors, AI-supported analytics, cloud-connected care, and hospital-to-home monitoring models.

Northeast

The Northeast represented approximately USD 2.48 billion in 2025 and is projected to reach around USD 6.31 billion by 2035, representing an estimated CAGR of approximately 9.8%.

The region includes Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, and Pennsylvania.

New York is the largest Northeast market because of its large population, extensive hospital infrastructure, high concentration of tertiary care, and substantial outpatient specialty networks. New York City alone supports major academic medical centers, cardiac programs, transplant centers, oncology facilities, neonatal programs, and critical-care infrastructure with significant monitoring requirements.

Massachusetts is smaller by population but disproportionately influential in medical technology adoption. Boston’s academic hospitals and clinical research environment make the state an important evaluation market for advanced neuromonitoring, wearable technology, AI-assisted surveillance, hemodynamic monitoring, and connected devices.

Pennsylvania provides a large and diverse market across Philadelphia, Pittsburgh, and regional health systems. The state combines urban tertiary care with substantial older and rural populations, creating demand for both advanced hospital monitoring and remote chronic-disease management.

New Jersey benefits from dense population, proximity to New York and Philadelphia healthcare markets, life-science industry concentration, and major hospital networks. Connecticut also has sophisticated provider systems and strong access to Northeast academic medicine.

Maine, New Hampshire, Vermont, and Rhode Island are smaller device markets but have important aging populations and, particularly in northern New England, rural access challenges. Remote monitoring, home blood pressure management, cardiac telemetry, and respiratory surveillance can provide significant value in these markets.

The Northeast is likely to grow below the national average because population growth is slower and the acute-care monitoring installed base is mature. Nevertheless, high procedure intensity, clinical research, specialist concentration, and willingness to adopt premium technologies will preserve strong revenue per patient and per facility.

Midwest

The Midwest represented approximately USD 2.00 billion in 2025 and is projected to reach around USD 5.00 billion by 2035, reflecting an estimated CAGR of approximately 9.6%.

The region includes Indiana, Illinois, Michigan, Ohio, Wisconsin, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota.

Illinois is the region’s largest population center and benefits from Chicago’s concentration of academic hospitals, community systems, specialist networks, and tertiary medical facilities. Demand spans ICU monitoring, cardiac telemetry, neonatal surveillance, glucose monitoring, ambulatory diagnostics, and hospital-wide device standardization.

Ohio is an important patient monitoring market because of its large hospital networks, academic centers, chronic-disease population, and substantial cardiovascular and neurological care infrastructure. Cleveland, Columbus, and Cincinnati support significant high-acuity monitoring demand.

Michigan has a substantial hospital and chronic-disease market centered on Detroit, Ann Arbor, Grand Rapids, and other regional hubs. Cardiac monitoring, diabetes management, respiratory monitoring, and critical-care surveillance remain important commercial categories.

Minnesota is strategically significant beyond its population because of its established medical-device ecosystem and sophisticated healthcare providers. The state is particularly influential in cardiovascular technologies, remote monitoring, data-driven care, and device innovation.

Indiana, Wisconsin, Missouri, Iowa, and Kansas provide stable demand across community hospitals, regional referral networks, ambulatory clinics, and chronic-disease management programs. Enterprise contracting and reliable service infrastructure can be particularly important in these markets.

Nebraska, North Dakota, and South Dakota have smaller populations spread across large geographic areas. Centralized monitoring and remote patient management offer an opportunity to extend specialist oversight while reducing unnecessary travel.

The Midwest is expected to remain a durable patient monitoring market rather than the fastest-growing one. Manufacturers can build share through enterprise health-system agreements, strong clinical service, reliable equipment, favorable lifecycle economics, and solutions that work effectively in both large academic centers and smaller regional hospitals.

 

Key Market Players

The U.S. Patient Monitoring Devices Competitive Landscape is moderately consolidated in hospital multiparameter monitoring but substantially more fragmented across ambulatory cardiac monitoring, glucose monitoring, remote physiological monitoring, respiratory monitoring, neuromonitoring, fetal monitoring, and wearable technologies.

Large manufacturers benefit from installed hospital infrastructure, service organizations, enterprise purchasing agreements, central-station platforms, interoperability, and extensive sensor portfolios. Specialist companies can compete effectively where they possess clinically differentiated algorithms, proprietary sensors, longer monitoring duration, stronger patient usability, or superior disease-specific workflows.

Some of the key players operating in the U.S. Patient Monitoring Devices industry are:

Koninklijke Philips N.V.
GE HealthCare Technologies Inc.
Medtronic plc
Masimo Corporation
Nihon Kohden Corporation
Baxter International Inc.
Drägerwerk AG & Co. KGaA
ICU Medical, Inc.
Edwards Lifesciences Corporation
Abbott Laboratories
Dexcom, Inc.
iRhythm Technologies, Inc.
Boston Scientific Corporation
OMRON Healthcare
ResMed Inc.
ZOLL Medical Corporation
Spacelabs Healthcare
Mindray
Natus Medical Incorporated
Nonin Medical, Inc.
BIOTRONIK
Schiller AG
Hillrom patient monitoring portfolio within Baxter
Senseonics Holdings, Inc.

Philips and GE HealthCare remain particularly important in hospital-based multiparameter monitoring because of their broad installed bases, central monitoring capabilities, enterprise relationships, and connections with other hospital technologies. Nihon Kohden, Dräger, Mindray, Spacelabs, Baxter, ICU Medical, and Masimo compete across bedside monitoring, telemetry, respiratory parameters, sensors, and acute-care workflows.

Masimo is strategically important because sensor performance and pulse oximetry create recurring consumable economics in addition to monitor hardware. Edwards Lifesciences maintains a strong position in advanced hemodynamic monitoring, where clinical decision support and higher-acuity procedural use support premium value.

Abbott and Dexcom are central to the rapidly expanding glucose-monitoring category, while Senseonics participates in implantable CGM. iRhythm is highly relevant to ambulatory cardiac monitoring and patch-based ECG workflows. Medtronic, Boston Scientific, BIOTRONIK, and ZOLL participate across cardiac monitoring and related cardiovascular surveillance technologies.

Competition through 2035 will increasingly center on ecosystem ownership rather than standalone hardware specifications. Vendors able to combine sensors, monitors, central surveillance, remote connectivity, analytics, electronic-record integration, service, and consumables can strengthen customer retention and improve lifetime revenue per installed system.

Hospital consolidation will favor suppliers capable of servicing national or multistate health systems. At the same time, rapid innovation in wearable and remote monitoring will allow specialist manufacturers to challenge incumbent vendors in applications where traditional bedside architecture is less important.

 

Recent Developments

Recent developments demonstrate that U.S. patient monitoring innovation is increasingly focused on next-generation bedside systems, wearable sensing, longer-duration continuous monitoring, advanced hemodynamics, and expansion of monitoring into non-traditional settings.

In February 2026, the FDA cleared Philips’ IntelliVue Multi-Measurement Module X3 and associated IntelliVue MX100 monitoring configurations. The clearance illustrates continued investment in modular physiological monitoring architectures that can support continuity across different hospital care environments.

Philips also received U.S. clearance in September 2025 for its IntelliVue Patient Monitor 6100, 6300, and 6500 systems. Continued regulatory activity in mainstream patient monitoring demonstrates that the hospital installed base remains an active innovation and replacement market even as industry attention shifts toward wearable monitoring.

In February 2026, the FDA cleared Edwards Lifesciences’ HemoSphere Nano Monitor. The development reinforces the continued evolution of advanced cardiovascular and hemodynamic monitoring toward more compact platforms designed to support clinical decision-making in higher-acuity care.

Continuous glucose monitoring has seen particularly important regulatory activity. Dexcom received FDA clearance for its G7 15 Day Continuous Glucose Monitoring System in April 2025, followed by additional G7 and G7 15 Day regulatory clearances in 2026. Longer wear duration is commercially important because it can reduce sensor changes, simplify patient routines, and improve the economics of continuous monitoring.

In June 2026, the FDA cleared the Stelo Glucose Biosensor System for over-the-counter use in children age two years and older who do not use insulin. The clearance represents a significant expansion of consumer-accessible medical monitoring and illustrates how regulated physiological monitoring is moving into everyday environments while retaining clinical-grade oversight.

The FDA is also actively cataloging authorized sensor-based digital health technologies, including wearables such as patches, rings, bands, and other technologies designed for continuous or spot monitoring outside traditional clinical settings. This regulatory direction supports continued innovation while raising the importance of validated performance.

Regulatory scrutiny is simultaneously increasing. In September 2025, the FDA warned healthcare providers and consumers against unauthorized devices that claim to measure or estimate blood pressure. The warning is commercially significant because it differentiates regulated medical monitoring from wellness technologies and creates a stronger quality barrier for companies entering blood pressure monitoring through smartwatches and other cuffless platforms.

Remote monitoring reimbursement remains another major strategic development. Medicare RPM utilization continued expanding in 2024, with payments exceeding USD 500 million. CMS continues to refine payment methodologies and remote-monitoring policy, meaning manufacturers and service providers must increasingly demonstrate that monitoring produces legitimate clinical management rather than passive data collection.

The combined effect of these developments is a competitive market in which device innovation, regulatory validation, reimbursement, cybersecurity, clinical workflow, and data analytics are converging. Manufacturers that view patient monitoring only as a hardware category risk losing relevance to companies building longitudinal surveillance platforms.

 

Conclusion

The U.S. Patient Monitoring Devices Market Size & Share is positioned for strong expansion from approximately USD 11.84 billion in 2025 to USD 32.14 billion by 2035, representing a 10.50% CAGR during 2026–2035.

The market’s growth is supported by a combination of structural factors that are unlikely to reverse during the forecast period: an aging U.S. population, a large chronic-disease burden, more than 900,000 staffed hospital beds, increasing use of connected physiological monitoring, growing remote patient monitoring reimbursement, continued hospital system consolidation, and a clinical shift from intermittent observation toward continuous surveillance.

The market will increasingly separate into two complementary value pools. The first is high-acuity monitoring, where hospitals continue to invest in multiparameter bedside systems, advanced hemodynamics, intensive-care monitoring, perioperative surveillance, central stations, and integrated sensors. The second is distributed monitoring, where wearable, ambulatory, and home-based devices extend physiological observation beyond conventional hospital boundaries.

Cardiac monitoring, continuous glucose monitoring, wearable multiparameter surveillance, respiratory monitoring, AI-assisted deterioration detection, remote blood pressure monitoring, neurological monitoring, and integrated central surveillance represent particularly attractive growth opportunities.

From a procurement perspective, the winning technologies will not necessarily be those with the greatest number of physiological parameters. U.S. hospitals increasingly need monitoring systems that produce fewer meaningless alarms, integrate cleanly into clinical records, travel with the patient, reduce staff workload, improve device utilization, support cybersecurity requirements, and demonstrate measurable clinical or economic value.

The South will remain the largest regional market because of population scale, chronic disease burden, older adult migration, and hospital expansion. The West is expected to record the fastest growth because of strong adoption of wearable, digital, cloud-connected, and AI-enabled monitoring. The Northeast will remain highly influential in clinical validation and premium technology adoption, while the Midwest will provide a stable installed base and significant health-system purchasing opportunity.

At the state level, California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, Georgia, North Carolina, Michigan, Massachusetts, Arizona, Washington, Minnesota, and Virginia will remain particularly important commercial markets. Texas and Florida offer especially strong growth potential through population expansion and chronic disease demand, while California continues to link large-scale healthcare delivery with digital and medtech innovation.

For companies, investors, hospital procurement executives, distributors, and strategic planners evaluating this market, the central issue is therefore not simply the number of monitoring devices sold. The more important question is how rapidly monitoring moves from episodic measurement toward continuous clinical intelligence.

Companies that successfully connect measurement, mobility, analytics, clinical prioritization, interoperability, reimbursement, and hospital-to-home continuity will define the next competitive cycle of the U.S. patient monitoring devices industry.

 

TABLE OF CONTENT

1. U.S. Patient Monitoring Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing, Triangulation & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Patient Monitoring Device Manufacturers
1.6.2. Sensor, Semiconductor and Component Suppliers
1.6.3. Contract Manufacturing and OEM Partners
1.6.4. Hospitals and Integrated Delivery Networks
1.6.5. Ambulatory Clinics, Specialty Practices and ASCs
1.6.6. Home Healthcare and Remote Monitoring Providers
1.6.7. Group Purchasing Organizations and Distributors
1.6.8. Health IT, EHR and Clinical Data Integration Providers
1.6.9. Payers, CMS, Regulators and Clinical Decision-Makers
What this section provides: This section defines the U.S. patient monitoring devices market boundary, research scope, methodology, assumptions, device ecosystem, and stakeholder structure so clients understand how the market is measured, segmented, validated, and forecast.

2. U.S. Patient Monitoring Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size & Growth Trajectory, 2021–2035
2.8. High-Growth Opportunity Areas
2.8.1. Continuous and Wearable Patient Monitoring
2.8.2. Remote Physiological Monitoring
2.8.3. Continuous Glucose Monitoring
2.8.4. Ambulatory Cardiac Monitoring
2.8.5. AI-Enabled Predictive Surveillance
2.8.6. Hospital-to-Home Monitoring Models
What this section provides: This section gives decision-makers a concise view of market size, historical development, forecast growth, technology shifts, demand concentration, competitive intensity, and the highest-priority opportunities through 2035.

3. U.S. Patient Monitoring Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising U.S. Chronic Disease Burden
3.1.2. Aging Population and Increasing Monitoring Intensity
3.1.3. Expansion of Continuous Monitoring Beyond Critical Care
3.1.4. Growth of Remote Patient Monitoring and Hospital-at-Home Models
3.1.5. Increasing Adoption of Continuous Glucose Monitoring
3.1.6. Growth in Ambulatory Cardiac Monitoring
3.1.7. Hospital Workforce Shortages and Monitoring Automation
3.1.8. Increasing Demand for Early Clinical Deterioration Detection
3.1.9. Growth of Connected and Interoperable Monitoring Platforms
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost of Enterprise Monitoring Platforms
3.2.2. Alarm Fatigue and Clinical Data Overload
3.2.3. Cybersecurity and Patient Data Privacy Risks
3.2.4. Interoperability and Legacy Infrastructure Constraints
3.2.5. Reimbursement and Remote Monitoring Compliance Complexity
3.2.6. Device Accuracy, Validation and False-Alarm Concerns
3.3. Opportunities and Their Impact Analysis
3.3.1. Wireless Medical-Surgical Floor Monitoring
3.3.2. AI-Based Predictive Patient Deterioration
3.3.3. Cuffless and Continuous Blood Pressure Monitoring
3.3.4. Long-Duration Wearable ECG Monitoring
3.3.5. Hospital-at-Home and Post-Discharge Monitoring
3.3.6. Rural and Underserved Population Monitoring
3.3.7. Centralized Virtual Monitoring Centers
3.3.8. Connected Chronic Disease Management
3.4. Challenges and Their Impact Analysis
3.4.1. Clinical Workflow Integration
3.4.2. Sensor Adherence and Patient Compliance
3.4.3. Device Fleet Standardization
3.4.4. Connectivity Reliability
3.4.5. Clinical Validation of AI Algorithms
3.4.6. Hospital Budget Prioritization
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.6.1. Nursing Workflow and Manual Vital-Sign Burden
3.6.2. Alarm Management Economics
3.6.3. Monitoring-Driven Early Intervention Economics
3.6.4. Length-of-Stay and Readmission Implications
3.6.5. Centralized Monitoring Workforce Economics
3.7. Hospital Capital Procurement Behavior Analysis
3.7.1. Bedside Monitor Replacement Cycles
3.7.2. Enterprise Standardization Decisions
3.7.3. Capital versus Operating Expense Models
3.7.4. Disposable Sensor Economics
3.7.5. Service Contract and Lifecycle Cost Analysis
What this section provides: This section explains the clinical, demographic, economic, reimbursement, workflow, and technology forces shaping U.S. patient monitoring demand, helping clients assess growth opportunities alongside adoption and execution risks.

4. U.S. Patient Monitoring Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.4.1. Sensors and Electronic Components
4.4.2. Monitor OEMs
4.4.3. Software and Connectivity Providers
4.4.4. Distribution and GPO Networks
4.4.5. Provider Delivery Channels
4.4.6. Home Monitoring Fulfillment
4.5. Impact of Digitalization and Connected Patient Monitoring
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.7.1. 510(k) Pathways
4.7.2. De Novo Classification
4.7.3. Premarket Approval Considerations
4.7.4. Software as a Medical Device
4.7.5. Cybersecurity Requirements
4.7.6. Wearable and Sensor-Based Medical Device Regulation
4.8. CMS Reimbursement and Coverage Landscape
4.8.1. Remote Physiological Monitoring Reimbursement
4.8.2. Remote Therapeutic Monitoring Interface
4.8.3. Medicare Hospital Reimbursement Considerations
4.8.4. Commercial Payer Coverage Environment
4.9. Import/Export Restrictions & Tariff Impact
4.10. Government Initiatives and Public Health Programs
4.11. Impact of Escalating Geopolitical and Supply Chain Tensions
4.12. Hospital Value Analysis Committee Decision Framework
4.12.1. Clinical Performance
4.12.2. Total Cost of Ownership
4.12.3. Workflow Impact
4.12.4. Interoperability
4.12.5. Cybersecurity
4.12.6. Sensor and Consumable Economics
What this section provides: This section gives clients a comprehensive view of regulation, reimbursement, pricing, technology, supply-chain exposure, connected-care adoption, and U.S. hospital procurement requirements affecting patient monitoring devices.

5. U.S. Patient Monitoring Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.2. Multi-Parameter Patient Monitoring Devices
5.2.1. High-Acuity Bedside Monitors
5.2.2. General Ward Patient Monitors
5.2.3. Portable and Transport Monitors
5.2.4. Central Monitoring Stations
5.2.5. Modular Patient Monitoring Systems
5.3. Cardiac Monitoring Devices
5.3.1. Resting ECG Systems
5.3.2. Holter Monitoring Systems
5.3.3. Event Monitoring Devices
5.3.4. Mobile Cardiac Telemetry
5.3.5. Wearable ECG Patch Monitors
5.3.6. Implantable Cardiac Monitors and Loop Recorders
5.3.7. Hospital Cardiac Telemetry Systems
5.4. Blood Glucose Monitoring Systems
5.4.1. Self-Monitoring Blood Glucose Systems
5.4.2. Continuous Glucose Monitoring Systems
5.4.3. CGM Sensors
5.4.4. CGM Transmitters and Readers
5.4.5. Professional and Institutional Glucose Monitoring
5.5. Respiratory Monitoring Devices
5.5.1. Pulse Oximeters
5.5.2. Capnography Systems
5.5.3. Respiratory Rate Monitoring Devices
5.5.4. Spirometry and Pulmonary Monitoring Systems
5.5.5. Sleep and Nocturnal Respiratory Monitoring Devices
5.6. Hemodynamic and Blood Pressure Monitoring Devices
5.6.1. Non-Invasive Blood Pressure Monitors
5.6.2. Ambulatory Blood Pressure Monitors
5.6.3. Invasive Blood Pressure Monitoring
5.6.4. Cardiac Output Monitoring
5.6.5. Advanced Hemodynamic Monitoring Platforms
5.7. Neuromonitoring Devices
5.7.1. EEG Monitoring Systems
5.7.2. Cerebral Oximetry Systems
5.7.3. Intracranial Pressure Monitoring
5.7.4. EMG and Neuromuscular Monitoring
5.7.5. Portable and Wearable Neurological Monitoring
5.8. Fetal and Neonatal Monitoring Devices
5.8.1. Fetal Heart Rate Monitoring
5.8.2. Maternal Monitoring Systems
5.8.3. Uterine Contraction Monitoring
5.8.4. Neonatal Cardiorespiratory Monitoring
5.8.5. Neonatal Pulse Oximetry and Temperature Monitoring
5.9. Temperature, Weight and Other Physiological Monitoring Devices
5.9.1. Temperature Monitoring Devices
5.9.2. Connected Weight Scales
5.9.3. Multi-Sensor Physiological Monitoring Devices
5.9.4. Other Specialized Monitoring Devices
What this section provides: This section identifies the patient monitoring product categories expected to generate the largest revenue contribution and strongest growth through 2035, including recurring sensor-based and connected monitoring opportunities.

6. U.S. Patient Monitoring Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.2. Critical Care and Acute Patient Surveillance
6.2.1. Intensive Care Monitoring
6.2.2. Emergency Department Monitoring
6.2.3. Medical-Surgical Ward Monitoring
6.2.4. Step-Down and Progressive Care Monitoring
6.3. Cardiovascular and Hypertension Management
6.3.1. Arrhythmia Detection
6.3.2. Hypertension Monitoring
6.3.3. Heart Failure Monitoring
6.3.4. Post-Cardiac Procedure Surveillance
6.4. Diabetes Management
6.4.1. Insulin-Treated Diabetes Monitoring
6.4.2. Non-Insulin Diabetes Monitoring
6.4.3. Inpatient Glucose Monitoring
6.4.4. Ambulatory and Home Glucose Monitoring
6.5. Respiratory and Sleep Monitoring
6.5.1. COPD Monitoring
6.5.2. Postoperative Respiratory Surveillance
6.5.3. Sleep-Disordered Breathing Monitoring
6.5.4. Home Oxygen and Respiratory Monitoring
6.6. Neurological Monitoring
6.6.1. Epilepsy and Seizure Monitoring
6.6.2. Neurocritical Care
6.6.3. Brain Injury Monitoring
6.6.4. Intraoperative Neuromonitoring
6.7. Maternal, Fetal and Neonatal Monitoring
6.7.1. Antepartum Monitoring
6.7.2. Intrapartum Monitoring
6.7.3. High-Risk Pregnancy Monitoring
6.7.4. NICU Monitoring
6.8. Perioperative and Postoperative Monitoring
6.8.1. Operating Room Monitoring
6.8.2. Post-Anesthesia Care Unit Monitoring
6.8.3. Procedural Sedation Monitoring
6.8.4. Ambulatory Surgery Monitoring
What this section provides: This section helps clients understand demand by clinical use case and prioritize monitoring applications with the strongest disease burden, patient volumes, reimbursement relevance, and technology adoption potential.

7. U.S. Patient Monitoring Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.2. Hospitals and Integrated Health Systems
7.2.1. Academic Medical Centers
7.2.2. Community Hospitals
7.2.3. Specialty Hospitals
7.2.4. Critical Access and Rural Hospitals
7.3. Ambulatory Clinics and Physician Practices
7.3.1. Cardiology Practices
7.3.2. Endocrinology and Diabetes Clinics
7.3.3. Pulmonology and Sleep Clinics
7.3.4. Neurology Practices
7.3.5. Primary Care Practices
7.4. Ambulatory Surgery Centers and Procedural Facilities
7.4.1. Multispecialty ASCs
7.4.2. Specialty ASCs
7.4.3. Office-Based Procedural Facilities
7.5. Home Healthcare and Remote Monitoring Providers
7.5.1. RPM Providers
7.5.2. Home Health Agencies
7.5.3. Hospital-at-Home Programs
7.5.4. Virtual Care Providers
7.6. Long-Term Care, Rehabilitation and Post-Acute Facilities
7.6.1. Skilled Nursing Facilities
7.6.2. Rehabilitation Centers
7.6.3. Assisted Living Facilities
7.6.4. Long-Term Acute Care Hospitals
7.7. Diagnostic and Specialty Monitoring Centers
7.7.1. Cardiac Diagnostic Centers
7.7.2. Sleep Diagnostic Centers
7.7.3. Neurological Diagnostic Centers
7.7.4. Maternal-Fetal Medicine Centers
What this section provides: This section explains which U.S. care settings and customer groups are expected to drive monitor purchasing, sensor utilization, enterprise standardization, ambulatory diagnostics, and recurring remote-monitoring demand.

8. U.S. Patient Monitoring Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.2. Conventional Bedside and Fixed Monitoring
8.2.1. Wired Bedside Monitoring
8.2.2. Fixed Central Monitoring
8.2.3. Modular High-Acuity Monitoring
8.3. Portable and Transport Monitoring
8.3.1. Portable Multi-Parameter Monitoring
8.3.2. Transport Monitoring
8.3.3. Handheld Monitoring Devices
8.4. Wireless and Wearable Monitoring
8.4.1. Wearable ECG Monitoring
8.4.2. Wireless Pulse Oximetry
8.4.3. Wearable Multi-Parameter Sensors
8.4.4. Wearable Temperature and Respiratory Sensors
8.4.5. Wearable Glucose Sensors
8.5. Remote and Cloud-Connected Monitoring
8.5.1. Remote Physiological Monitoring Platforms
8.5.2. Cloud-Connected Medical Devices
8.5.3. Home Monitoring Hubs and Gateways
8.5.4. Centralized Virtual Monitoring Platforms
8.6. AI-Enabled and Predictive Monitoring
8.6.1. AI-Assisted Arrhythmia Detection
8.6.2. Predictive Patient Deterioration Algorithms
8.6.3. Automated Alarm Prioritization
8.6.4. AI-Enabled Neurological Monitoring
8.6.5. Multi-Parameter Predictive Analytics
What this section provides: This section evaluates the monitoring technologies reshaping U.S. care delivery, from conventional bedside equipment to portable systems, wearables, cloud-connected devices, remote surveillance, and AI-enabled predictive monitoring.

9. U.S. Patient Monitoring Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.2. Direct Hospital and Health System Procurement
9.2.1. Capital Equipment Procurement
9.2.2. Sensor and Consumable Procurement
9.2.3. Software and Service Agreements
9.3. Integrated Delivery Network Enterprise Contracts
9.3.1. Multi-Hospital Platform Standardization
9.3.2. Enterprise Monitoring Infrastructure Agreements
9.3.3. Long-Term Service and Lifecycle Contracts
9.4. Group Purchasing Organization Contracts
9.4.1. National GPO Agreements
9.4.2. Regional Purchasing Networks
9.4.3. Aggregated Sensor and Consumable Contracts
9.5. Distributor and Specialty Supplier Sales
9.5.1. Medical Device Distributors
9.5.2. Home Medical Equipment Suppliers
9.5.3. Specialty Monitoring Distributors
9.6. Ambulatory, Homecare and Digital Procurement
9.6.1. Physician Practice Procurement
9.6.2. ASC Procurement
9.6.3. Remote Monitoring Device Fulfillment
9.6.4. Direct-to-Patient Medical Device Distribution
What this section provides: This section explains how patient monitoring devices are purchased and deployed across the U.S., including hospital capital procurement, IDN standardization, GPO contracting, distribution, outpatient purchasing, and remote-monitoring fulfillment.

10. U.S. Patient Monitoring Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Hospital Bed and Care Infrastructure Analysis
10.1.4. Regional Chronic Disease and Aging Population Analysis
10.1.5. Regional Remote Monitoring Adoption Analysis
10.1.6. Regional Reimbursement and Procurement Dynamics

10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Patient Monitoring Device Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Patient Monitoring Device Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Patient Monitoring Device Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Patient Monitoring Device Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
What this section provides: This section delivers detailed four-region and all-50-state analysis, enabling clients to identify priority geographies, hospital infrastructure hubs, chronic-disease demand centers, remote-monitoring opportunities, adoption hotspots, and state-level commercial potential.

11. U.S. Patient Monitoring Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Company Profiles
11.3.1. Koninklijke Philips N.V.
11.3.2. GE HealthCare Technologies Inc.
11.3.3. Medtronic plc
11.3.4. Masimo Corporation
11.3.5. Nihon Kohden Corporation
11.3.6. Baxter International Inc.
11.3.7. Drägerwerk AG & Co. KGaA
11.3.8. ICU Medical, Inc.
11.3.9. Edwards Lifesciences Corporation
11.3.10. Abbott Laboratories
11.3.11. Dexcom, Inc.
11.3.12. iRhythm Technologies, Inc.
11.3.13. Boston Scientific Corporation
11.3.14. OMRON Healthcare
11.3.15. ResMed Inc.
11.3.16. ZOLL Medical Corporation
11.3.17. Spacelabs Healthcare
11.3.18. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
11.3.19. Natus Medical Incorporated
11.3.20. Nonin Medical, Inc.
11.3.21. BIOTRONIK
11.3.22. SCHILLER AG
11.3.23. Senseonics Holdings, Inc.
11.3.24. AliveCor, Inc.
11.3.25. BioIntelliSense, Inc.
Note: Each company profile will include company overview, U.S. patient monitoring portfolio, product positioning, U.S. market strategy, financial positioning where available, installed-base strategy, regulatory developments, innovation pipeline, partnerships, acquisitions, interoperability strategy, and recent developments.
11.4. Competitive Benchmarking by Product Portfolio
11.5. Competitive Benchmarking by Technology Capability
11.6. Competitive Benchmarking by U.S. Care Setting
11.7. Competitive Benchmarking by Remote Monitoring Capability
11.8. Mergers, Acquisitions, Partnerships and Strategic Alliances, 2021–2026
What this section provides: This section gives clients competitor benchmarking, market-share visibility, product portfolio positioning, innovation direction, installed-base intelligence, remote-monitoring capabilities, and strategic profiles of major patient monitoring companies.

12. U.S. Patient Monitoring Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Wearable Multi-Parameter Monitoring
12.2.2. AI-Based Predictive Patient Deterioration
12.2.3. Next-Generation Continuous Glucose Monitoring
12.2.4. Cuffless and Continuous Blood Pressure Monitoring
12.2.5. Remote Patient Monitoring and Hospital-at-Home Platforms
12.2.6. Centralized Virtual Patient Surveillance
12.3. Emerging Business Trends
12.3.1. Hardware-to-Platform Business Model Transition
12.3.2. Sensor-Based Recurring Revenue Models
12.3.3. Subscription and Monitoring-as-a-Service Models
12.3.4. Hospital-to-Home Care Continuity
12.3.5. Enterprise Monitoring Standardization
12.3.6. AI-Enabled Clinical Command Centers
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.5.1. Market Attractiveness
12.5.2. Clinical Unmet Need
12.5.3. Competitive Intensity
12.5.4. Reimbursement Potential
12.5.5. Regulatory Risk
12.5.6. Scalability Potential
12.6. Technology Adoption Roadmap, 2026–2035
What this section provides: This section prepares clients for future technology shifts, evolving monitoring architectures, business-model changes, adoption scenarios, investment priorities, and disruptive technologies expected to reshape the U.S. patient monitoring devices market through 2035.

13. U.S. Patient Monitoring Devices Market: Strategic Recommendations

13.1. Recommendations for Patient Monitoring Device Manufacturers
13.1.1. Portfolio Prioritization
13.1.2. Connected Platform Strategy
13.1.3. Sensor and Consumable Revenue Strategy
13.1.4. Clinical Evidence Strategy
13.2. Recommendations for Hospitals and Integrated Health Systems
13.2.1. Enterprise Monitoring Standardization
13.2.2. Alarm Management Strategy
13.2.3. Monitoring Interoperability Strategy
13.2.4. Capital Replacement Planning
13.3. Recommendations for Investors and Private Equity Firms
13.3.1. High-Growth Device Categories
13.3.2. Recurring Revenue Opportunities
13.3.3. Platform Consolidation Opportunities
13.3.4. Technology and Regulatory Due Diligence
13.4. Recommendations for Distributors and Channel Partners
13.4.1. Hospital Channel Strategy
13.4.2. Ambulatory Market Expansion
13.4.3. Home Monitoring Fulfillment
13.4.4. Sensor and Consumable Distribution
13.5. Recommendations for New Entrants and Startups
13.5.1. Clinical Differentiation
13.5.2. FDA Strategy
13.5.3. Reimbursement Strategy
13.5.4. Hospital Pilot-to-Scale Strategy
13.6. Go-to-Market Strategy Considerations
13.6.1. IDN Targeting
13.6.2. KOL and Academic Center Strategy
13.6.3. GPO Access
13.6.4. Regional Commercial Prioritization
13.7. Product Positioning and Portfolio Expansion Guidance
13.8. U.S. State-Level Commercial Prioritization Framework
What this section provides: This section converts market intelligence into actionable strategy for market entry, product development, portfolio expansion, hospital targeting, channel strategy, investment decisions, geographic prioritization, and competitive differentiation.

14. U.S. Patient Monitoring Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Market Estimation and Rounding Disclaimer
14.7. Company and Product Information Disclaimer
What this section provides: This section clarifies the report’s scope limitations, legal boundaries, third-party data considerations, market-estimation methodology limitations, forecasting assumptions, and appropriate use of the research.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Patient Monitoring Devices Market: Market Definition and Scope
TABLE 3: U.S. Patient Monitoring Devices Market: Research Methodology Framework
TABLE 4: U.S. Patient Monitoring Devices Market: Key Assumptions
TABLE 5: U.S. Patient Monitoring Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Patient Monitoring Devices Market: Stakeholder Analysis
TABLE 7: U.S. Patient Monitoring Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Patient Monitoring Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Patient Monitoring Devices Market: Market Attractiveness Index
TABLE 10: U.S. Patient Monitoring Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Patient Monitoring Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Patient Monitoring Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Patient Monitoring Devices Market: High-Growth Opportunity Areas
TABLE 14: U.S. Patient Monitoring Devices Market: Drivers; Impact Analysis
TABLE 15: U.S. Patient Monitoring Devices Market: Restraints; Impact Analysis
TABLE 16: U.S. Patient Monitoring Devices Market: Opportunities; Impact Analysis
TABLE 17: U.S. Patient Monitoring Devices Market: Challenges; Impact Analysis
TABLE 18: U.S. Patient Monitoring Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 19: U.S. Patient Monitoring Devices Market: Clinical Workflow Economics Matrix
TABLE 20: U.S. Patient Monitoring Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 21: U.S. Patient Monitoring Devices Market: PESTEL Analysis
TABLE 22: U.S. Patient Monitoring Devices Market: Porter’s Five Forces Analysis
TABLE 23: U.S. Patient Monitoring Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 24: U.S. Patient Monitoring Devices Market: Value Chain Analysis
TABLE 25: U.S. Patient Monitoring Devices Market: Supply Chain Analysis
TABLE 26: U.S. Patient Monitoring Devices Market: Digitalization and Connected Monitoring Impact
TABLE 27: U.S. Patient Monitoring Devices Market: Application & Innovation Landscape
TABLE 28: U.S. Patient Monitoring Devices Market: FDA Regulatory Framework Analysis
TABLE 29: U.S. Patient Monitoring Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 30: U.S. Patient Monitoring Devices Market: Import/Export Restrictions & Tariff Impact
TABLE 31: U.S. Patient Monitoring Devices Market: Government Initiatives and Public Health Programs
TABLE 32: U.S. Patient Monitoring Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 33: U.S. Patient Monitoring Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 34: U.S. Patient Monitoring Devices Market: Product Category Snapshot, 2025
TABLE 35: Segment Dashboard; Definition and Scope, by Product Category
TABLE 36: U.S. Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 37: U.S. Patient Monitoring Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 38: U.S. Patient Monitoring Devices Market: Multi-Parameter Patient Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 39: U.S. Patient Monitoring Devices Market: Cardiac Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 40: U.S. Patient Monitoring Devices Market: Blood Glucose Monitoring Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Patient Monitoring Devices Market: Respiratory Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Patient Monitoring Devices Market: Hemodynamic and Blood Pressure Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. Patient Monitoring Devices Market: Neuromonitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Patient Monitoring Devices Market: Fetal and Neonatal Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Patient Monitoring Devices Market: Temperature, Weight and Other Physiological Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Patient Monitoring Devices Market: Application Snapshot, 2025
TABLE 47: Segment Dashboard; Definition and Scope, by Application
TABLE 48: U.S. Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 49: U.S. Patient Monitoring Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 50: U.S. Patient Monitoring Devices Market: Critical Care and Acute Patient Surveillance Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Patient Monitoring Devices Market: Cardiovascular and Hypertension Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Patient Monitoring Devices Market: Diabetes Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Patient Monitoring Devices Market: Respiratory and Sleep Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Patient Monitoring Devices Market: Neurological Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Patient Monitoring Devices Market: Maternal, Fetal and Neonatal Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Patient Monitoring Devices Market: Perioperative and Postoperative Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Patient Monitoring Devices Market: End User Snapshot, 2025
TABLE 58: Segment Dashboard; Definition and Scope, by End User
TABLE 59: U.S. Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 60: U.S. Patient Monitoring Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 61: U.S. Patient Monitoring Devices Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: U.S. Patient Monitoring Devices Market: Ambulatory Clinics and Physician Practices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Patient Monitoring Devices Market: Ambulatory Surgery Centers and Procedural Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Patient Monitoring Devices Market: Home Healthcare and Remote Monitoring Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Patient Monitoring Devices Market: Long-Term Care, Rehabilitation and Post-Acute Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Patient Monitoring Devices Market: Diagnostic and Specialty Monitoring Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Patient Monitoring Devices Market: Technology Type Snapshot, 2025
TABLE 68: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 69: U.S. Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 70: U.S. Patient Monitoring Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 71: U.S. Patient Monitoring Devices Market: Conventional Bedside and Fixed Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Patient Monitoring Devices Market: Portable and Transport Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Patient Monitoring Devices Market: Wireless and Wearable Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Patient Monitoring Devices Market: Remote and Cloud-Connected Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Patient Monitoring Devices Market: AI-Enabled and Predictive Monitoring Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Patient Monitoring Devices Market: Procurement Channel Snapshot, 2025
TABLE 77: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 78: U.S. Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 79: U.S. Patient Monitoring Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 80: U.S. Patient Monitoring Devices Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Patient Monitoring Devices Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Patient Monitoring Devices Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Patient Monitoring Devices Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Patient Monitoring Devices Market: Ambulatory, Homecare and Digital Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Patient Monitoring Devices Market: Regional Snapshot, 2025
TABLE 86: Segment Dashboard; Definition and Scope, by Region
TABLE 87: U.S. Patient Monitoring Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 88: U.S. Patient Monitoring Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 89: West Region U.S. Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 90: West Region U.S. Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 91: West Region U.S. Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 92: West Region U.S. Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 97: California Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 98: California Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 99: California Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 100: California Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 101: California Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 102: Washington Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 103: Washington Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 104: Washington Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 105: Washington Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 106: Washington Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 107: Arizona Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 108: Arizona Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 109: Arizona Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 110: Arizona Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 111: Arizona Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 112: Colorado Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 113: Colorado Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 114: Colorado Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 115: Colorado Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 116: Colorado Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 117: Oregon Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 118: Oregon Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 119: Oregon Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 120: Oregon Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 121: Oregon Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 122: Utah Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 123: Utah Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 124: Utah Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 125: Utah Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 126: Utah Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 127: Nevada Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 128: Nevada Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 129: Nevada Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 130: Nevada Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 131: Nevada Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 132: New Mexico Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 133: New Mexico Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 134: New Mexico Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 135: New Mexico Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 136: New Mexico Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 137: Idaho Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 138: Idaho Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 139: Idaho Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 140: Idaho Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 141: Idaho Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 142: Montana Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 143: Montana Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 144: Montana Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 145: Montana Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 146: Montana Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 147: Wyoming Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 148: Wyoming Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 149: Wyoming Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 150: Wyoming Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 151: Wyoming Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 152: Alaska Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 153: Alaska Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 154: Alaska Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 155: Alaska Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 156: Alaska Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 157: Hawaii Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 158: Hawaii Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 159: Hawaii Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 160: Hawaii Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 161: Hawaii Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 162: Northeast Region U.S. Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 163: Northeast Region U.S. Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 164: Northeast Region U.S. Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 165: Northeast Region U.S. Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 166: Northeast Region U.S. Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 167: Northeast Region U.S. Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 168: Northeast Region U.S. Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 169: Northeast Region U.S. Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 170: New York Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 171: New York Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 172: New York Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 173: New York Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 174: New York Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 175: Massachusetts Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 176: Massachusetts Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 177: Massachusetts Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 178: Massachusetts Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 179: Massachusetts Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 180: New Jersey Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 181: New Jersey Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 182: New Jersey Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 183: New Jersey Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 184: New Jersey Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 185: Pennsylvania Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 186: Pennsylvania Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 187: Pennsylvania Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 188: Pennsylvania Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 189: Pennsylvania Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 190: Connecticut Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 191: Connecticut Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 192: Connecticut Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 193: Connecticut Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 194: Connecticut Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 195: Maine Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 196: Maine Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 197: Maine Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 198: Maine Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 199: Maine Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 200: Vermont Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 201: Vermont Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 202: Vermont Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 203: Vermont Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 204: Vermont Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 205: New Hampshire Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 206: New Hampshire Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 207: New Hampshire Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 208: New Hampshire Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 209: New Hampshire Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 210: Rhode Island Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 211: Rhode Island Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 212: Rhode Island Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 213: Rhode Island Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 214: Rhode Island Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 215: Delaware Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 216: Delaware Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 217: Delaware Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 218: Delaware Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 219: Delaware Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 220: South Region U.S. Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 221: South Region U.S. Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 222: South Region U.S. Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 223: South Region U.S. Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 224: South Region U.S. Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 225: South Region U.S. Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 226: South Region U.S. Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 227: South Region U.S. Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 228: Texas Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 229: Texas Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 230: Texas Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 231: Texas Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 232: Texas Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 233: Florida Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 234: Florida Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 235: Florida Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 236: Florida Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 237: Florida Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 238: Georgia Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 239: Georgia Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 240: Georgia Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 241: Georgia Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 242: Georgia Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 243: North Carolina Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 244: North Carolina Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 245: North Carolina Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 246: North Carolina Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 247: North Carolina Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 248: Tennessee Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 249: Tennessee Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 250: Tennessee Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 251: Tennessee Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 252: Tennessee Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 253: South Carolina Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 254: South Carolina Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 255: South Carolina Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 256: South Carolina Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 257: South Carolina Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 258: Alabama Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 259: Alabama Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 260: Alabama Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 261: Alabama Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 262: Alabama Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 263: Mississippi Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 264: Mississippi Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 265: Mississippi Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 266: Mississippi Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 267: Mississippi Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 268: Louisiana Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 269: Louisiana Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 270: Louisiana Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 271: Louisiana Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 272: Louisiana Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 273: Arkansas Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 274: Arkansas Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 275: Arkansas Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 276: Arkansas Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 277: Arkansas Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 278: Kentucky Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 279: Kentucky Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 280: Kentucky Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 281: Kentucky Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 282: Kentucky Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 283: Oklahoma Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 284: Oklahoma Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 285: Oklahoma Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 286: Oklahoma Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 287: Oklahoma Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 288: Virginia Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 289: Virginia Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 290: Virginia Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 291: Virginia Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 292: Virginia Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 293: Maryland Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 294: Maryland Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 295: Maryland Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 296: Maryland Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 297: Maryland Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 298: West Virginia Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 299: West Virginia Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 300: West Virginia Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 301: West Virginia Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 302: West Virginia Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 303: Midwest Region U.S. Patient Monitoring Devices Market: Regional Overview and Trends
TABLE 304: Midwest Region U.S. Patient Monitoring Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 305: Midwest Region U.S. Patient Monitoring Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 306: Midwest Region U.S. Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 307: Midwest Region U.S. Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 308: Midwest Region U.S. Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 309: Midwest Region U.S. Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 310: Midwest Region U.S. Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 311: Illinois Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 312: Illinois Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 313: Illinois Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 314: Illinois Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 315: Illinois Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 316: Ohio Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 317: Ohio Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 318: Ohio Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 319: Ohio Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 320: Ohio Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 321: Michigan Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 322: Michigan Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 323: Michigan Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 324: Michigan Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 325: Michigan Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 326: Minnesota Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 327: Minnesota Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 328: Minnesota Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 329: Minnesota Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 330: Minnesota Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 331: Indiana Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 332: Indiana Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 333: Indiana Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 334: Indiana Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 335: Indiana Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 336: Wisconsin Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 337: Wisconsin Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 338: Wisconsin Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 339: Wisconsin Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 340: Wisconsin Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 341: Missouri Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 342: Missouri Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 343: Missouri Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 344: Missouri Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 345: Missouri Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 346: Iowa Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 347: Iowa Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 348: Iowa Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 349: Iowa Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 350: Iowa Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 351: Kansas Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 352: Kansas Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 353: Kansas Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 354: Kansas Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 355: Kansas Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 356: Nebraska Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 357: Nebraska Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 358: Nebraska Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 359: Nebraska Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 360: Nebraska Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 361: North Dakota Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 362: North Dakota Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 363: North Dakota Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 364: North Dakota Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 365: North Dakota Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 366: South Dakota Patient Monitoring Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 367: South Dakota Patient Monitoring Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 368: South Dakota Patient Monitoring Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 369: South Dakota Patient Monitoring Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 370: South Dakota Patient Monitoring Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 371: U.S. Patient Monitoring Devices Market: Competitive Landscape Snapshot, 2025
TABLE 372: U.S. Patient Monitoring Devices Market: Key Company Market Share Analysis, 2025
TABLE 373: U.S. Patient Monitoring Devices Market: Company Positioning Matrix
TABLE 374: U.S. Patient Monitoring Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 375: U.S. Patient Monitoring Devices Market: Technology Capability Benchmarking of Key Players
TABLE 376: U.S. Patient Monitoring Devices Market: U.S. Care Setting Competitive Benchmarking
TABLE 377: U.S. Patient Monitoring Devices Market: Remote Monitoring Capability Benchmarking
TABLE 378: U.S. Patient Monitoring Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 379: Koninklijke Philips N.V.: Company Profile
TABLE 380: GE HealthCare Technologies Inc.: Company Profile
TABLE 381: Medtronic plc: Company Profile
TABLE 382: Masimo Corporation: Company Profile
TABLE 383: Nihon Kohden Corporation: Company Profile
TABLE 384: Baxter International Inc.: Company Profile
TABLE 385: Drägerwerk AG & Co. KGaA: Company Profile
TABLE 386: ICU Medical, Inc.: Company Profile
TABLE 387: Edwards Lifesciences Corporation: Company Profile
TABLE 388: Abbott Laboratories: Company Profile
TABLE 389: Dexcom, Inc.: Company Profile
TABLE 390: iRhythm Technologies, Inc.: Company Profile
TABLE 391: Boston Scientific Corporation: Company Profile
TABLE 392: OMRON Healthcare: Company Profile
TABLE 393: ResMed Inc.: Company Profile
TABLE 394: ZOLL Medical Corporation: Company Profile
TABLE 395: Spacelabs Healthcare: Company Profile
TABLE 396: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.: Company Profile
TABLE 397: Natus Medical Incorporated: Company Profile
TABLE 398: Nonin Medical, Inc.: Company Profile
TABLE 399: BIOTRONIK: Company Profile
TABLE 400: SCHILLER AG: Company Profile
TABLE 401: Senseonics Holdings, Inc.: Company Profile
TABLE 402: AliveCor, Inc.: Company Profile
TABLE 403: BioIntelliSense, Inc.: Company Profile
TABLE 404: U.S. Patient Monitoring Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 405: U.S. Patient Monitoring Devices Market: Disruptive Technologies Impact Matrix
TABLE 406: U.S. Patient Monitoring Devices Market: Emerging Business Trends
TABLE 407: U.S. Patient Monitoring Devices Market: Business Opportunities for Startups and Existing Players
TABLE 408: U.S. Patient Monitoring Devices Market: Investment Prioritization Matrix
TABLE 409: U.S. Patient Monitoring Devices Market: Technology Adoption Roadmap, 2026–2035
TABLE 410: U.S. Patient Monitoring Devices Market: Strategic Recommendations for Patient Monitoring Device Manufacturers
TABLE 411: U.S. Patient Monitoring Devices Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 412: U.S. Patient Monitoring Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 413: U.S. Patient Monitoring Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 414: U.S. Patient Monitoring Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 415: U.S. Patient Monitoring Devices Market: Go-to-Market Strategy Considerations
TABLE 416: U.S. Patient Monitoring Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 417: U.S. Patient Monitoring Devices Market: U.S. State-Level Commercial Prioritization Framework
TABLE 418: U.S. Patient Monitoring Devices Market: Scope Limitation
TABLE 419: U.S. Patient Monitoring Devices Market: Data Use Limitation
TABLE 420: U.S. Patient Monitoring Devices Market: Forecasting Limitation
TABLE 421: U.S. Patient Monitoring Devices Market: Legal Disclaimer
TABLE 422: U.S. Patient Monitoring Devices Market: Third-Party Data Disclaimer
TABLE 423: U.S. Patient Monitoring Devices Market: Market Estimation and Rounding Disclaimer
TABLE 424: U.S. Patient Monitoring Devices Market: Company and Product Information Disclaimer

List of Figures

FIGURE 1: U.S. Patient Monitoring Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Hospital Capital Procurement Decision Framework
FIGURE 12: U.S. Patient Monitoring Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 13: U.S. Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 14: U.S. Patient Monitoring Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 15: U.S. Patient Monitoring Devices Market High-Growth Opportunity Map
FIGURE 16: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 17: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Multi-Parameter Patient Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Cardiac Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Blood Glucose Monitoring Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Respiratory Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Hemodynamic and Blood Pressure Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Neuromonitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Fetal and Neonatal Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Temperature, Weight and Other Physiological Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 27: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Critical Care and Acute Patient Surveillance Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Cardiovascular and Hypertension Management Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Diabetes Management Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Respiratory and Sleep Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Neurological Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Maternal, Fetal and Neonatal Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Perioperative and Postoperative Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 36: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Ambulatory Clinics and Physician Practices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Ambulatory Surgery Centers and Procedural Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Home Healthcare and Remote Monitoring Providers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Long-Term Care, Rehabilitation and Post-Acute Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Diagnostic and Specialty Monitoring Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 44: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Conventional Bedside and Fixed Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Portable and Transport Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Wireless and Wearable Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Remote and Cloud-Connected Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: AI-Enabled and Predictive Monitoring Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 51: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Ambulatory, Homecare and Digital Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 58: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: West Region U.S. Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 60: West Region Market Share Analysis by State, 2025
FIGURE 61: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: California Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Washington Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Arizona Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Colorado Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Oregon Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Utah Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Nevada Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: New Mexico Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Idaho Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Montana Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Wyoming Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Alaska Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Hawaii Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Northeast Region U.S. Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 76: Northeast Region Market Share Analysis by State, 2025
FIGURE 77: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: New York Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Massachusetts Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: New Jersey Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Pennsylvania Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Connecticut Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Maine Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Vermont Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: New Hampshire Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Rhode Island Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Delaware Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: South Region U.S. Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 89: South Region Market Share Analysis by State, 2025
FIGURE 90: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Texas Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Florida Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Georgia Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: North Carolina Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Tennessee Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: South Carolina Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Alabama Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Mississippi Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Louisiana Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Arkansas Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Kentucky Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Oklahoma Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Virginia Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Maryland Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: West Virginia Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Midwest Region U.S. Patient Monitoring Devices Market Share and Leading Players, 2025
FIGURE 107: Midwest Region Market Share Analysis by State, 2025
FIGURE 108: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Illinois Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Ohio Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Michigan Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Minnesota Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Indiana Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Wisconsin Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Missouri Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Iowa Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Kansas Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Nebraska Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: North Dakota Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: South Dakota Patient Monitoring Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 122: Company Positioning Matrix
FIGURE 123: Key Player Product Portfolio Benchmarking
FIGURE 124: Key Player Technology Capability Benchmarking
FIGURE 125: Competitive Benchmarking by U.S. Care Setting
FIGURE 126: Remote Monitoring Capability Benchmarking
FIGURE 127: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 128: Patient Monitoring Device Innovation Roadmap
FIGURE 129: Future Market Scenario Analysis, 2026–2035
FIGURE 130: Disruptive Technologies Impact Matrix
FIGURE 131: Emerging Business Trends Matrix
FIGURE 132: Investment Prioritization Matrix
FIGURE 133: Technology Adoption Roadmap, 2026–2035
FIGURE 134: Strategic Growth Roadmap for U.S. Patient Monitoring Device Companies
FIGURE 135: Go-to-Market Strategy Framework
FIGURE 136: Product Positioning and Portfolio Expansion Framework
FIGURE 137: U.S. State-Level Commercial Prioritization Framework
FIGURE 138: Report Scope and Disclaimer Framework